First report of warfarin dose requirements in patients possessing the CYP2C9*12 allele. [electronic resource]
Producer: 20140410Description: 73-5 p. digitalISSN:- 1873-3492
- Aged
- Aged, 80 and over
- Alleles
- Amino Acid Substitution
- Anticoagulants -- metabolism
- Apolipoproteins E -- genetics
- Aryl Hydrocarbon Hydroxylases -- genetics
- Base Sequence
- Biotransformation
- Cytochrome P-450 CYP2C9
- Drug Dosage Calculations
- Female
- Genotype
- Genotyping Techniques
- Heterozygote
- Humans
- Male
- Middle Aged
- Molecular Sequence Data
- Mutation
- Thromboembolism -- enzymology
- Vitamin K Epoxide Reductases -- genetics
- Warfarin -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.